口腔鳞状细胞癌时辰化疗中国专家共识

doi:10.19438/j.cjoms.2019.01.002

中国口腔颌面外科杂志 ›› 2019, Vol. 17 ›› Issue (1): 7-12.doi: 10.19438/j.cjoms.2019.01.002

口腔鳞状细胞癌时辰化疗中国专家共识

杨凯^1#, 郭伟^2#, 孙沫逸³, 郑家伟², 李龙江⁴, 唐瞻贵⁵, 任国欣², 陈丹¹, 吕晓强¹, 张杰⁶, 韩正学⁷, 席庆⁸, 孙志军⁹, 陈晓品¹⁰, 张涛¹⁰, 车宗刚¹¹, 冉炜¹², 孟箭¹³, 黄桂林¹⁴, 唐洪¹, 肖灿¹⁵

1.重庆医科大学附属第一医院口腔颌面外科,重庆 400016;
2.上海交通大学医学院附属第九人民医院·口腔医学院口腔颌面-头颈肿瘤科,上海 200011;;
3.空军军医大学第三附属医院（第四军医大学口腔医学院）口腔颌面外科,陕西西安 710032;
4.四川大学华西口腔医学院头颈肿瘤外科,四川成都 610041;
5.中南大学湘雅口腔医学院口腔颌面外科,湖南长沙 410013;
6.北京大学口腔医学院口腔颌面外科,北京 100081;
7.首都医科大学附属北京口腔医院口腔颌面-头颈肿瘤外科,北京 100050;
8.中国人民解放军总医院第一医学中心口腔科,北京 100853;
9.武汉大学口腔医学院口腔颌面-头颈肿瘤外科,湖北武汉 430079;
10.重庆医科大学附属第一医院肿瘤科,重庆 400016;
11.淄博市中心医院口腔颌面外科,山东淄博 255036;
12.中山大学附属第一医院口腔颌面外科,广东广州 510080;
13.徐州市中心医院口腔颌面外科,江苏徐州 221009;
14.遵义医科大学附属口腔医院口腔颌面外科,贵州遵义 563000;
15.苏州大学附属第一医院口腔科,江苏苏州 215006

收稿日期:2018-11-10 修回日期:2018-12-16 出版日期:2019-01-20 发布日期:2019-02-21
通讯作者: 郭伟,E-mail:guoweicn@yahoo.com;杨凯,E-mail:cqfyyk@aliyun.com。^#共同通信作者
作者简介:杨凯（1965-）,男,教授,主任医师,博士研究生（博士后）导师

Chinese expert consensus on chrono-chemotherapy for oral squamous cell carcinoma

YANG Kai¹, GUO Wei², SUN Mo-yi³, ZHENG Jia-wei², LI Long-jiang⁴, TANG Zhan-gui⁵, REN Guo-xin², CHEN Dan¹, LV Xiao-qiang¹, ZHANG Jie⁶, HAN Zheng-xue⁷, XI Qing⁸, SUN Zhi-jun⁹, CHEN Xiao-pin¹⁰, ZHANG Tao¹⁰, CHE Zong-gang¹¹, RAN Wei¹², MENG Jian¹³, HUANG Gui-lin¹⁴, TANG Hong¹, XIAO Can¹⁵

1.Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Chongqing Medical University. Chongqing 400016;
2.Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine. Shanghai 200011;
3. Department of Oral and Maxillofacial Surgery, The Third Affiliated Hospital, Air Force Medical University School of Stomatology, Fourth Military Medical University. Xi'an 710032, Shaanxi Province;
4.Department of Head and Neck Oncology Surgery, West China Hospital of Stomatology, Sichuan University. Chengdu 610041, Sichuan Province;
5. Department of Oral and Maxillofacial Surgery, Xiangya School of Stomatology, Central South University. Changsha 410013, Hunan Province;
6.Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Peking University. Beijing 100081;
7.Department of Oromaxillofacial Head and Neck Oncology Surgery, Beijing Stomatological Hospital, Capital Medical University. Beijing 100050;
8. Stomatological Department of 1st Medical Center, Chinese PLA General Hospital. Beijing 100853;
9.Department of Oromaxillofacial Head and Neck Oncology Surgery, School and Hospital of Stomatology, Wuhan University. Wuhan 430079, Hubei Province;
10.Department of Oncology, The First Affiliated Hospital of Chongqing Medical University. Chongqing 400016;
11.Department of Oral and Maxillofacial Surgery, Zibo Central Hospital. Zibo 255036, Shandong Province;
12. Department of Oral and Maxillofacial Surgery, First Affiliated Hospital of Sun Yat-sen University. Guangzhou 510080, Guangdong Province;
13. Department of Oral and Maxillofacial Surgery, Xuzhou Central Hospital. Xuzhou 221009, Jiangsu Province;
14.Department of Oral and Maxillofacial Surgery, Stomatological Hospital, Zunyi Medical University. Zunyi 563000, Guizhou Province;
15.Department of Stomatology, The First Affiliated Hospital of Soochow University. Suzhou 215006, Jiangsu Province, China

Received:2018-11-10 Revised:2018-12-16 Online:2019-01-20 Published:2019-02-21

摘要/Abstract

摘要： 化疗是口腔鳞癌的主要治疗方法之一,也是口腔鳞癌综合治疗的重要组成部分。然而,化疗药物在体内既杀伤癌细胞又杀伤正常细胞的“双刃剑”作用,使其临床应用受到一定限制。基于人体昼夜节律变化规律进行的时辰化疗比常规化疗更安全和更有效已被大量研究所证实,为了推广和规范该技术的临床应用,我们组织相关专家讨论并制定了专家共识。该共识对口腔鳞癌时辰化疗的原则、药物选择、给药时间和方法等给出了规范化建议,可供临床实践参考。

关键词: 口腔鳞癌, 时辰化疗, 昼夜节律, 生物钟, 专家共识

Abstract: Chemotherapy is one of the main methods for treatment of oral squamous cell carcinoma, and it is also an important part of comprehensive treatment of oral squamous cell carcinoma. However, the "double-edged sword" effect of chemotherapeutic drugs in killing both cancer cells and normal cells in vivo has restricted its clinical application to a certain extent. Chrono-chemotherapy based on human circadian rhythm is safer and more effective than traditional chemotherapy, which has been confirmed by a large number of studies. In order to promote and standardize the clinical application of this technology, we organized relevant experts to discuss and formulate the chinese expert consensus. The consensus provides standardized suggestions on the principles, drug selection, administration time and methods of chrono-chemotherapy for oral squamous cell carcinoma, which can provide reference for clinical practice.

Key words: Oral squamous cell carcinoma, Chrono-chemotherapy, Circadian rhythm, Circadian clock, Expert consensus

中图分类号:

R739.8

杨凯, 郭伟, 孙沫逸, 郑家伟, 李龙江, 唐瞻贵, 任国欣, 陈丹, 吕晓强, 张杰, 韩正学, 席庆, 孙志军, 陈晓品, 张涛, 车宗刚, 冉炜, 孟箭, 黄桂林, 唐洪, 肖灿. 口腔鳞状细胞癌时辰化疗中国专家共识[J]. 中国口腔颌面外科杂志, 2019, 17(1): 7-12.

YANG Kai, GUO Wei, SUN Mo-yi, ZHENG Jia-wei, LI Long-jiang, TANG Zhan-gui, REN Guo-xin, CHEN Dan, LV Xiao-qiang, ZHANG Jie, HAN Zheng-xue, XI Qing, SUN Zhi-jun, CHEN Xiao-pin, ZHANG Tao, CHE Zong-gang, RAN Wei, MENG Jian, HUANG Gui-lin, TANG Hong, XIAO Can. Chinese expert consensus on chrono-chemotherapy for oral squamous cell carcinoma[J]. China J Oral Maxillofac Surg, 2019, 17(1): 7-12.

参考文献

[1] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30.
[2] Pfister D, Spencer S, Adelstein D, et al. NCCN clinical practice guidelines in oncology (NCCN Guidelines^®) for head and neck cancers. Version 2.2018. Fort Washington: National Comprehensive Cancer Network (NCCN) [DB/OL]. 2018. https://www.nccn.org/professionals/physician_gls/default.aspx.
[3] 中国临床肿瘤学会指南工作委员会.头颈部肿瘤诊疗指南2018.V1[DB/OL].中国临床肿瘤学会(CSCO).2018. http://www.csco.org.cn/.
[4] 曹雨庵, 郭伟. 我国口腔鳞癌的治疗现状[J]. 实用肿瘤杂志, 2012, 27(2): 109-112.
[5] Ballesta A, Innominato PF, Dallmann R, et al.Systems chronotherapeutics[J]. Pharmacol Rev, 2017, 69(2): 161-199.
[6] Ortiz-Tudela E, Innominato PF, Rol MA, et al.Relevance of internal time and circadian robustness for cancer patients[J]. BMC Cancer, 2016, 16: 285.
[7] Ozturk N, Ozturk D, Kavakli IH, et al.Molecular aspects of circadian pharmacology and relevance for cancer chronotherapy[J]. Int J Mol Sci, 2017, 18(10) : E2168.
[8] FitzGerald GA. Circadian rhythms.Temporal targets of drug action[J]. Science, 2014, 346(6212): 921-922.
[9] Sehgal A.Physiology flies with time[J]. Cell, 2017, 171(6):1232-1235.
[10] Turek FW.Circadian clocks: Not your grandfather's clock[J]. Science, 2016, 354(6315): 992-993.
[11] Innominato PF, Roche VP, Palesh OG, et al.The circadian timing system in clinical oncology[J]. Ann Med, 2014, 46(4): 191-207.
[12] Innominato PF, Lévi FA, Bjarnason GA.Chronotherapy and the molecular clock: Clinical implications in oncology[J]. Adv Drug Deliv Rev, 2010, 62(9-10): 979-1001.
[13] Ortiz-Tudela E, Mteyrek A, Ballesta A, et al.Cancer chronotherapeutics: experimental, theoretical, and clinical aspects[J]. Handb Exp Pharmacol, 2013, (217): 261-288.
[14] Lévi F, Okyar A, Dulong S, at el. Circadian timing in cancer treatments[J]. Annu Rev Pharmacol Toxicol, 2010, 50: 377-421.
[15] Sancar A, Lindsey-Boltz LA, Gaddameedhi S, at el. Circadian clock, cancer, and chemotherapy[J]. Biochemistry, 2015, 54(2): 110-123.
[16] 杨凯, 陈睿, 喻秀丽. 口腔癌时辰化疗[J]. 实用口腔医学杂志, 2005, 21(3): 389-391.
[17] Chen D, Cheng J, Yang K, et al.Retrospective analysis of chronomodulated chemotherapy versus conventional chemotherapy with paclitaxel, carboplatin, and 5-fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma[J]. Onco Targets Ther, 2013, 6: 1507-1514.
[18] Ye H, Yang K, Tan XM, et al.Daily rhythm variations of the clock gene PER1 and cancer-related genes during various stages of carcinogenesis in a golden hamster model of buccal mucosa carcinoma[J]. Onco Targets Ther, 2015, 8: 1419-1426.
[19] Callaway E, Ledford H.Medicine Nobel awarded for work on circadian clocks[J]. Nature, 2017, 550(7674): 18.
[20] Zhang R, Lahens NF, Ballance HI, et al.A circadian gene expression atlas in mammals: implications for biology and medicine[J]. Proc Natl Acad Sci USA, 2014, 111(45): 16219-16224.
[21] 赵宁波, 杨凯, 唐洪, 等. 奥沙利铂对口腔鳞状细胞癌的时辰治疗[J]. 华西口腔医学杂志, 2013, 31(2): 131-135.
[22] Zhao N, Tang H, Yang K, et al.Circadian rhythm characteristics of oral squamous cell carcinoma growth in an orthotopic xenograft model[J]. Onco Targets Ther, 2013, 6: 41-46.
[23] Hori K, Zhang QH, Li HC, et al.Timing of cancer chemotherapy based on circadian variations in tumor tissue blood flow[J]. Int J Cancer, 1996, 65(3): 360-364.
[24] Blumenthal RD, Osorio L, Ochakovskaya R, et al.Regulation of tumour drug delivery by blood flow chronobiology[J]. Eur J Cancer, 2000, 36(14):1876-1884.
[25] 杨凯, 张福军, 李雅冬, 等. 时辰新辅助化疗治疗老年人口腔鳞癌的临床研究[J]. 中华老年口腔医学杂志, 2005, 3(1): 23-25.
[26] Tsuchiya Y, Ushijima K, Noguchi T, et al.Influence of a dosing-time on toxicities induced by docetaxel, cisplatin and 5-fluorouracil in patients with oral squamous cell carcinoma; a cross-over pilot study[J]. Chronobiol Int, 2018, 35(2): 289-294.
[27] Therasse P, Arbuck SG, Eisenhauer EA, et al.New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada[J]. J Natl Cancer Inst, 2000, 92(3): 205-216.
[28] Eisenhauer EA, Therasse P, Bogaerts J, et al.New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)[J]. Eur J Cancer, 2009, 45(2): 228-247.
[29] HHS, NIH, NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 [DB/OL].2009. http://evs.nci.nih.gov/ftp1/CTCAE/About.html.

口腔鳞状细胞癌时辰化疗中国专家共识

Chinese expert consensus on chrono-chemotherapy for oral squamous cell carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	陈华, 李婧, 罗梅. 红景天甙通过NRF2/KEAP1通路对口腔鳞癌细胞生长的影响[J]. 中国口腔颌面外科杂志, 2024, 22(5): 424-429.
[2]	邰茂众, 秦中平, 郑家伟, 李克雷, 刘学键, 李凯, 袁斯明, 范新东, 周德凯, 董长宪, 吉毅, 顾松, 霍然, 杨耀武, 王绪凯. 局限性血管内凝血诊断与治疗中国专家共识[J]. 中国口腔颌面外科杂志, 2024, 22(4): 313-321.
[3]	黄灿, 罗涛, 孙宇. 改良衰弱评估对行口腔鳞癌皮瓣重建术老年患者术后并发症的预测价值[J]. 中国口腔颌面外科杂志, 2024, 22(4): 373-377.
[4]	王延安, 秦中平, 郑家伟, 李春洁, 刘少华, 杨耀武, 陈刚, 陈伟良, 刘学键, 杜仲, 张雷, 王业飞, 王德明, 苏立新, 谢峰, 董长宪, 郭磊, 李凯, 顾松, 何悦, 张志愿. 头颈部血管瘤及脉管畸形手术治疗专家共识[J]. 中国口腔颌面外科杂志, 2024, 22(2): 105-117.
[5]	任振虎，陈铭韬，吴汉江，张胜，方坤，谢尚，刘宇，胡传宇，刘冰，李春洁，朱桂全，王成，高洋，张晓晨，石剑波，张永红，崔明哲，季彤，任国欣，王延安，陈伟良，张陈平，何悦，张志愿. 头颈肿瘤围术期静脉血栓栓塞症防治中国专家共识[J]. 中国口腔颌面外科杂志, 2024, 22(1): 1-9.
[6]	李华盛, 周迪, 韩楠男, 严明, 阮敏. 石蒜碱通过降解SCAP蛋白抑制口腔鳞癌细胞增殖与侵袭的实验研究[J]. 中国口腔颌面外科杂志, 2024, 22(1): 29-35.
[7]	刘恒, 李永頔, 尹鑫海, 段晓峰. 铁蛋白重链1在头颈鳞癌中的表达及对口腔鳞癌增殖、迁移、侵袭的影响[J]. 中国口腔颌面外科杂志, 2023, 21(6): 529-537.
[8]	赵铜超, 梁思源, 周知航, 朱方兴, 琚梧桐, 谈亦然, 刘莹, 钟来平. BMI与局部晚期口腔鳞癌患者预后及诱导化疗效果的相关性研究[J]. 中国口腔颌面外科杂志, 2023, 21(6): 559-565.
[9]	朱方兴, 周知航, 琚梧桐, 谈亦然, 刘莹, 钟来平, 赵铜超. 基于基线期dNLR水平对局部晚期口腔鳞癌患者生存的预后预测—10年临床回顾[J]. 中国口腔颌面外科杂志, 2023, 21(6): 566-571.
[10]	靳能皓, 田瑜, 朱亮, 乔波, 李粮博, 张海钟, 张蕾. PD-L1及肿瘤免疫微环境对预测口腔鳞癌新辅助治疗效果的意义[J]. 中国口腔颌面外科杂志, 2023, 21(6): 572-578.
[11]	何悦, 陈珩, 安金刚, 郭玉兴, 潘剑, 田磊, 刘冰, 侯劲松, 李劲松, 蒋灿华, 李萌宇, 田臻, 许洁, 朱凌, 孙长伏, 郅克谦, 瞿晴, 宗春琳, 孙晶晶, 张志愿. 药物相关性颌骨坏死临床诊疗专家共识[J]. 中国口腔颌面外科杂志, 2023, 21(4): 313-325.
[12]	吴朱昊, 张兴伟, 孙亚威, 李子慧, 陈欣, 蒲玉梅, 胡勤刚, 董迎春, 孙国文. ICG荧光导航技术在晚期口腔鳞癌救治性手术中的应用[J]. 中国口腔颌面外科杂志, 2023, 21(3): 248-252.
[13]	刘恒, 段晓峰. 铁自噬及相关基因NCOA4、FTH1在口腔鳞癌中的研究进展[J]. 中国口腔颌面外科杂志, 2023, 21(1): 87-91.
[14]	季萍萍, 李莉, 吴奕帆, 侯黎莉. 经皮穴位电刺激防治口腔鳞癌患者诱导化疗后骨髓抑制的效果观察[J]. 中国口腔颌面外科杂志, 2022, 20(5): 455-460.
[15]	许刚, 宋其义, 蒋卫东, 刘景秀. 水通道蛋白3在口腔鳞癌中的表达及临床意义[J]. 中国口腔颌面外科杂志, 2022, 20(5): 478-482.